Praluent (alirocumab) Drug Interactions
There are no known drug interactions for Praluent (alirocumab) - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Praluent (alirocumab) is in the drug class PCSK9 inhibitors. Praluent (alirocumab) is used to treat the following conditions: Cardiovascular Risk Reduction, High Cholesterol, High Cholesterol, Familial Heterozygous, High Cholesterol, Familial Homozygous.
More about Praluent (alirocumab)
- Praluent Side Effects
- During Pregnancy
- Dosage Information
- Support Group
- Pricing & Coupons
- 56 Reviews
- Drug class: PCSK9 inhibitors
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.